{
    "2020-03-17": [
        [
            {
                "time": "",
                "original_text": "泰格医药拟赴港上市，或成为第三家“A+H”CRO企业",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "赴港上市",
                        "A+H",
                        "CRO企业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "研发服务外包全产业链2019 Preview：细分篇",
                "features": {
                    "keywords": [
                        "研发服务",
                        "外包",
                        "全产业链",
                        "2019 Preview",
                        "细分篇"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "研发"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "第三家“A+H”CRO企业来了：泰格医药拟赴港上市",
                "features": {
                    "keywords": [
                        "第三家",
                        "A+H",
                        "CRO企业",
                        "泰格医药",
                        "赴港上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}